TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.0969
+0.0008 (0.83%)
Oct 23, 2025, 1:16 PM CET
TME Pharma Revenue
In the year 2024, TME Pharma had annual revenue of 19.00K EUR with 11.76% growth. TME Pharma had revenue of 19.00K in the half year ending December 31, 2024.
Revenue
19.00K
Revenue Growth
+11.76%
P/S Ratio
474.04
Revenue / Employee
1.58K
Employees
12
Market Cap
9.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.00K | 2.00K | 11.76% |
| Dec 31, 2023 | 17.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 33.00K | -2.00K | -5.71% |
| Dec 31, 2020 | 35.00K | -119.00K | -77.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.74B |
| EssilorLuxottica Société anonyme | 27.24B |
| Eurofins Scientific SE | 7.14B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| bioMérieux | 4.12B |
| Ipsen | 3.76B |
| Sartorius Stedim Biotech | 2.95B |